Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China
· Delayed Price · Currency is CNY 41.22
+2.07 (5.29%)
Apr 29, 2026, 3:04 PM CST
SHE:300255 Revenue
Hebei Changshan Biochemical Pharmaceutical had revenue of 256.10M CNY in the quarter ending March 31, 2026, a decrease of -1.00%. This brings the company's revenue in the last twelve months to 872.53M, down -12.33% year-over-year. In the year 2025, Hebei Changshan Biochemical Pharmaceutical had annual revenue of 875.13M, down -15.10%.
Revenue (ttm)
872.53M
Revenue Growth
-12.33%
P/S Ratio
41.24
Revenue / Employee
695.80K
Employees
1,254
Market Cap
35.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 875.13M | -155.68M | -15.10% |
| Dec 31, 2024 | 1.03B | -379.63M | -26.92% |
| Dec 31, 2023 | 1.41B | -925.79M | -39.63% |
| Jan 1, 2023 | 2.34B | -631.82M | -21.29% |
| Jan 1, 2022 | 2.97B | 604.26M | 25.56% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai RAAS Blood Products | 7.35B |
| Chongqing Zhifei Biological Products | 10.91B |
| Shanghai Allist Pharmaceuticals | 5.67B |
| Asymchem Laboratories (Tianjin) | 6.67B |
| Beijing Tiantan Biological Products | 6.17B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.32B |
| Beijing Wantai Biological Pharmacy Enterprise | 1.82B |
| Pharmaron Beijing | 14.10B |